Real-world use of a hydrophilic curcumin-based oral formulation in the management of macular oedema: a collection of clinical experiences

Davide Allegrini, Giuseppe Covello, Alessandra Mancini, Antonino Mancini, Maura Mancini, Mary Romano, Aldo Vecchiarelli, Mario R Romano

Article Type

Real-World Study

Published

This is a collection of clinical experiences exploring the real-world effectiveness of a hydrophilic curcuminbased oral formulation (CHC, Diabec) in the management of macular oedema across diverse retinal conditions

Read more

Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study

Giorgio Walter Canonica, Piotr Kuna, Marcus Maurer, Ralph Mösges, Zoltan Novak, Nikolaus Papadopoulos, Pablo Rodriguez del Rio, the Delphi Study Group

Article Type

Original Research

Published

This study analyses available evidence supporting the use of bilastine amongst second-generation antihistamines for the symptomatic treatment of allergic rhinitis and urticaria in adults and children.

Read more

The role of hypochlorous acid in the management of eye infections: a case series

Chiara Bertone, Antonella Mollicone, Stefano Russo, Paola Sasso, Romina Fasciani, Cinzia Riccardi, Mirella Lizzano, the ALI working group

Article Type

Case Series

Published

This case series presents and discusses real-life experiences with using an hypochlorous acid (HOCl) ophthalmic spray to manage eye infections, further characterizing the use of HOCl for ophthalmic applications.

Read more

Conjunctivitis in patients with atopic dermatitis treated with dupilumab

Sandra Ferreira MD, Tiago Torres MD, PhD

Article Type

Review

Published

The present paper reviews the data of dupilumab-associated conjunctivitis and risk factors in adults with moderate-to-severe AD and other atopic diseases in dupilumab clinical trials and addresses the characteristics and treatment options available for this clinically highly relevant condition.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.